A common observation in drug delivery studies is that preincubation of nanoparticles (NPs) with high concentrations of human plasma (HP) markedly reduces in vitro transfection efficiency (TE). This effect is commonly attributed to the formation of a protein corona (PC), which is assumed to impair cellular uptake or intracellular trafficking of gene delivery systems such as lipid nanoparticles (LNPs). However, the evidence presented here suggests an alternative mechanism underlying this phenomenon. To reproduce conditions in which LNPs encounter an excess of circulating proteins, NPs were incubated in HP prior to exposure to cells in standard calcium‐containing culture medium. Under these conditions, plasma undergoes gelation, leading to the formation of a clot‐like network. A combination of complementary approaches, including dynamic light scattering (DLS), fluorescence‐activated cell sorting (FACS), confocal fluorescence microscopy, raster image correlation spectroscopy (RICS), and functional assays evaluating TE and cell viability, demonstrates that this gel‐like matrix restricts LNP diffusion in the extracellular environment. In contrast, coronated LNPs that reach the intracellular space display comparable trafficking behavior, indicating that the PC does not compromise intracellular processing. These findings highlight the importance of extracellular factors when evaluating the impact of the PC and extrapolating in vitro results to in vivo settings.
Lipid nanoparticles (LNPs) preferentially accumulate in the liver, but hepatic tropism alone does not ensure productive RNA interference. Here, we screened a library of LNPs in which lipid composition was varied to generate distinct protein corona identities and identify formulations capable of combining liver accumulation with functional siRNA delivery. LNP1 emerged as the lead formulation, showing favorable physicochemical properties, high transfection efficiency, and enhanced hepatic accumulation. Proteomic analysis associated this behavior with a distinct multicomponent corona signature. When loaded with siRNA targeting tissue inhibitor of metalloproteinases 1 (TIMP1), a key regulator of extracellular matrix turnover and fibrosis, LNP1 was efficiently internalized by primary Kupffer cells (KCs) and induced robust target knockdown. Consistent with this cellular preference, quartz crystal microbalance measurements showed that corona formation increased LNP1 binding to MARCO, a scavenger receptor expressed by KCs. In a mouse model of primary biliary cholangitis, repeated administration of siTIMP1‐loaded LNP1 reduced TIMP1 expression in KCs, reactivated extracellular‐matrix‐degradative pathways, suppressed pro‐inflammatory signaling and macrophage infiltration, alleviated cholestasis and attenuated liver fibrosis. These findings connect systematic variation in lipid composition with corona identity, hepatic tropism, and functional gene silencing, supporting protein corona engineering as a strategy to bridge liver accumulation with productive siRNA delivery.